351 related articles for article (PubMed ID: 38596241)
1. Glioblastoma modeling with 3D organoids: progress and challenges.
Wang X; Sun Y; Zhang DY; Ming GL; Song H
Oxf Open Neurosci; 2023; 2():kvad008. PubMed ID: 38596241
[TBL] [Abstract][Full Text] [Related]
2. Modeling glioblastoma complexity with organoids for personalized treatments.
Pawlowski KD; Duffy JT; Babak MV; Balyasnikova IV
Trends Mol Med; 2023 Apr; 29(4):282-296. PubMed ID: 36805210
[TBL] [Abstract][Full Text] [Related]
3. A novel neuronal organoid model mimicking glioblastoma (GBM) features from induced pluripotent stem cells (iPSC).
Hwang JW; Loisel-Duwattez J; Desterke C; Latsis T; Pagliaro S; Griscelli F; Bennaceur-Griscelli A; Turhan AG
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129540. PubMed ID: 31978452
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional culture models to study glioblastoma - current trends and future perspectives.
Joseph JV; Blaavand MS; Daubon T; Kruyt FA; Thomsen MK
Curr Opin Pharmacol; 2021 Dec; 61():91-97. PubMed ID: 34656940
[TBL] [Abstract][Full Text] [Related]
5. Anti-glioblastoma activity of monensin and its analogs in an organoid model of cancer.
Urbaniak A; Reed MR; Heflin B; Gaydos J; Piña-Oviedo S; Jędrzejczyk M; Klejborowska G; Stępczyńska N; Chambers TC; Tackett AJ; Rodriguez A; Huczyński A; Eoff RL; MacNicol AM
Biomed Pharmacother; 2022 Sep; 153():113440. PubMed ID: 36076555
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma.
Sundar SJ; Shakya S; Barnett A; Wallace LC; Jeon H; Sloan A; Recinos V; Hubert CG
Transl Oncol; 2022 Jan; 15(1):101251. PubMed ID: 34700192
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy.
Klein E; Hau AC; Oudin A; Golebiewska A; Niclou SP
Front Oncol; 2020; 10():604121. PubMed ID: 33364198
[TBL] [Abstract][Full Text] [Related]
8. Organoid Models of Glioblastoma and Their Role in Drug Discovery.
Rybin MJ; Ivan ME; Ayad NG; Zeier Z
Front Cell Neurosci; 2021; 15():605255. PubMed ID: 33613198
[TBL] [Abstract][Full Text] [Related]
9. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
Qu J; Kalyani FS; Liu L; Cheng T; Chen L
Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models.
Suarez-Meade P; Watanabe F; Ruiz-Garcia H; Rafferty SB; Moniz-Garcia D; Schiapparelli PV; Jentoft ME; Imitola J; Quinones-Hinojosa A
J Neurooncol; 2023 Jan; 161(1):67-76. PubMed ID: 36595192
[TBL] [Abstract][Full Text] [Related]
11. Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications.
Weth FR; Peng L; Paterson E; Tan ST; Gray C
Cells; 2022 Dec; 12(1):. PubMed ID: 36611949
[TBL] [Abstract][Full Text] [Related]
12. Organoid models of glioblastoma: advances, applications and challenges.
Zhang C; Jin M; Zhao J; Chen J; Jin W
Am J Cancer Res; 2020; 10(8):2242-2257. PubMed ID: 32905502
[TBL] [Abstract][Full Text] [Related]
13. Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics.
Krieger TG; Tirier SM; Park J; Jechow K; Eisemann T; Peterziel H; Angel P; Eils R; Conrad C
Neuro Oncol; 2020 Aug; 22(8):1138-1149. PubMed ID: 32297954
[TBL] [Abstract][Full Text] [Related]
14. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
[TBL] [Abstract][Full Text] [Related]
15. Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture.
Sundar SJ; Shakya S; Recinos V; Hubert CG
J Vis Exp; 2022 Aug; (186):. PubMed ID: 36094291
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.
Azzarelli R; Ori M; Philpott A; Simons BD
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33619017
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Glioma Models: From Patients to Dish to Animals.
da Hora CC; Schweiger MW; Wurdinger T; Tannous BA
Cells; 2019 Sep; 8(10):. PubMed ID: 31574953
[TBL] [Abstract][Full Text] [Related]
18. Patient-derived glioblastoma stem cells transfer mitochondria through tunneling nanotubes in tumor organoids.
Pinto G; Saenz-de-Santa-Maria I; Chastagner P; Perthame E; Delmas C; Toulas C; Moyal-Jonathan-Cohen E; Brou C; Zurzolo C
Biochem J; 2021 Jan; 478(1):21-39. PubMed ID: 33245115
[TBL] [Abstract][Full Text] [Related]
19. Development of glioblastoma organoids and their applications in personalized therapy.
Xu C; Yuan X; Hou P; Li Z; Wang C; Fang C; Tan Y
Cancer Biol Med; 2023 Jun; 20(5):353-68. PubMed ID: 37283493
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system organoids for modeling neurodegenerative diseases.
Hou PS; Kuo HC
IUBMB Life; 2022 Aug; 74(8):812-825. PubMed ID: 35102668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]